The biotech’s stock has been sliding hard over the past month and half for two related reasons: Vaxart’s oral COVID-19 vaccine pill may not be on the market until the pandemic is starting to fade from the daily news cycle.
Similarly Why is VXRT going up? Shares of clinical-stage vaccine developer Vaxart ( VXRT 3.96% ) are up again today, gaining 12.34% to $9.83 apiece as of 2:30 p.m. EDT. The stock is up 21% over the past five trading days due to greater capital inflows after the company released encouraging second-quarter earnings on Aug. 5.
What happen with VXRT? (VXRT) Reports Q4 Loss, Lags Revenue Estimates. VAXART, INC. (VXRT) delivered earnings and revenue surprises of 0% and 69.55%, respectively, for the quarter ended December 2021.
Additionally, Should I invest in vaxart?
Valuation metrics show that VAXART, INC. may be overvalued. Its Value Score of F indicates it would be a bad pick for value investors. The financial health and growth prospects of VXRT, demonstrate its potential to underperform the market.
Is vaxart a good stock?
The verdict. While Vaxart’s oral vaccine could be a game-changer if approved, it is nowhere near reaching that milestone. A lot can still go wrong for the company, and since it does not currently have any products on the market and is consistently unprofitable, that makes the company’s shares very risky.
How do I buy vaxart stock? How to buy shares in Vaxart
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. …
- Purchase now or later. …
- Check in on your investment.
